FDA Adverse Event Malfunction Summary report: N

ACCESS TOTAL BHCG (5TH IS) ASSAY

MDR report key: 4220038 · Received November 3, 2014

Report

Report Number
2122870-2014-00751
Event Type
Malfunction
Date Received
November 3, 2014
Date of Event
July 21, 2014
Report Date
October 3, 2014
Manufacturer
BECKMAN COULTER
Product Code
DHA
PMA / PMN Number
K130020
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BECKMAN COULTER (BEC) FIELD SERVICE WAS NOT DISPATCHED TO EVALUATE THE INSTRUMENT. THERE WAS NO INDICATION THE ACCESS TBHCG REAGENT WAS RETURNED TO BEC FOR INVESTIGATION. THE PATIENT SAMPLE WAS SENT TO THE BEC COMPLAINT HANDLING UNIT (CHU) FOR TESTING. THE SAMPLE WAS CENTRIFUGED AND TESTED NEAT, IN DUPLICATE, BY AN ACCESS 2 IMMUNOASSAY SYSTEM (SERIAL NUMBER (B)(4)), WHICH GENERATED REPRODUCIBLE TBHCG5 RESULTS; THE CUSTOMER'S REPORTED ISSUE COULD NOT BE DUPLICATED. IN CONCLUSION, THE CAUSE OF THE NON-REPRODUCIBLE TBHCG5 RESULTS COULD NOT BE DETERMINED WITH THE SUPPLIED INFORMATION. (B)(6). ALL ASSOCIATED MDRS: 2122870-2014-00595, 2122870-2014-00752, 2122870-2014-00754.

Description of Event or Problem · 1

THE CUSTOMER REPORTED A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM (SERIAL NUMBER (B)(4)) GENERATED NON-REPRODUCIBLE TOTAL BETA HUMAN CHORIONIC GONADOTROPIN (TBHCG5) RESULTS FOR FOUR PATIENT SAMPLES ON FOUR DATES. THIS MDR REPORTS THE RESULTS GENERATED ON (B)(6) 2014 FOR ONE PATIENT. THERE WERE NO REPORTS OF IMPACT TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT. THE CUSTOMER DID NOT REPORT ANY INSTRUMENT-GENERATED FLAGS OR HARDWARE ERRORS AT THE TIME OF THE EVENT. THERE WERE NO ISSUES NOTED WITH SAMPLE COLLECTION, SAMPLING HANDLING, OR SAMPLING PROCESSING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
703858 ACCESS TOTAL BHCG (5TH IS) ASSAY SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN DHA BECKMAN COULTER NA 333264

Patients

Seq Age Sex Outcome Treatment
1 36 YR